TMX Newsfile

IN THE PRESS

Press Releases

Izotropic Announces Non-Brokered Private Placement

September 25, 2026

·

3 min read

Press Releases

Medexus Holds Annual Meeting of Shareholders and Announces Election of Directors

September 24, 2026

·

3 min read

Press Releases

OS Therapies Announces Brand Name ‘Herlystic’ Approved by World Health Organization for OST-HER2 (daznelimgene lisbac)

September 24, 2026

·

7 min read

Press Releases

TempraMed Expands Latin American Distribution Agreement with TEM and Receives Additional Commercial Order, Announces Private Placement

September 24, 2026

·

12 min read

Press Releases

Phio Pharmaceuticals to Present Clinical Development Update and Upcoming Catalysts at Life Sciences Future 2026 Conference

September 23, 2026

·

5 min read

Press Releases

TempraMed Announces Distribution Agreement with CenterWell Pharmacy(R), the Pharmacy Services Brand of Humana

September 23, 2026

·

3 min read

Press Releases

Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio

September 22, 2026

·

1 min read

Press Releases

DIMERx Secures Second NIH Award to Advance DMX-201 for Sickle Cell Disease

September 22, 2026

·

1 min read

Press Releases

OS Therapies Completes FDA Type C Statistical Methods Meeting and Provides Update on Global Regulatory Coordination for OST-HER2 Under Project Orbis

September 21, 2026

·

7 min read

Press Releases

BioMark Announces Participation in upcoming MSACL 2026 and BIOHorizon 2026 Life Sciences Conferences

September 21, 2026

·

4 min read

15 Toronto St., Suite 601 Toronto ON M5C 2E3 US

Tel: 416-806-1750